- Home
- PRQR vs SNFCA Comparison
PRQR vs SNFCA Comparison
Compare PRQR & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- SNFCA
- Stock Information
- Founded
- PRQR 2012
- SNFCA 1965
- Country
- PRQR Netherlands
- SNFCA United States
- Employees
- PRQR N/A
- SNFCA N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- SNFCA Finance: Consumer Services
- Sector
- PRQR Health Care
- SNFCA Finance
- Exchange
- PRQR Nasdaq
- SNFCA Nasdaq
- Market Cap
- PRQR 232.8M
- SNFCA 236.8M
- IPO Year
- PRQR 2014
- SNFCA N/A
- Fundamental
- Price
- PRQR $2.06
- SNFCA $8.85
- Analyst Decision
- PRQR Strong Buy
- SNFCA
- Analyst Count
- PRQR 8
- SNFCA 0
- Target Price
- PRQR $8.88
- SNFCA N/A
- AVG Volume (30 Days)
- PRQR 368.1K
- SNFCA 37.5K
- Earning Date
- PRQR 11-06-2025
- SNFCA 11-13-2025
- Dividend Yield
- PRQR N/A
- SNFCA N/A
- EPS Growth
- PRQR N/A
- SNFCA 2.26
- EPS
- PRQR N/A
- SNFCA 0.89
- Revenue
- PRQR $20,129,184.00
- SNFCA $339,824,006.00
- Revenue This Year
- PRQR N/A
- SNFCA N/A
- Revenue Next Year
- PRQR N/A
- SNFCA N/A
- P/E Ratio
- PRQR N/A
- SNFCA $10.06
- Revenue Growth
- PRQR 8.65
- SNFCA 5.49
- 52 Week Low
- PRQR $1.07
- SNFCA $7.32
- 52 Week High
- PRQR $4.62
- SNFCA $12.94
- Technical
- Relative Strength Index (RSI)
- PRQR 42.63
- SNFCA 53.92
- Support Level
- PRQR $1.91
- SNFCA $8.59
- Resistance Level
- PRQR $2.50
- SNFCA $8.87
- Average True Range (ATR)
- PRQR 0.16
- SNFCA 0.29
- MACD
- PRQR -0.04
- SNFCA 0.04
- Stochastic Oscillator
- PRQR 25.42
- SNFCA 70.59
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.